Litcius/Paper detail

Dapagliflozin Protects H9c2 Cells Against Injury Induced byLipopolysaccharide via Suppression of CX3CL1/CX3CR1 Axis and NF-κBActivity

Yousef Faridvand, Maryam Nemati, Elham Zamani-Gharehchamani, Hamid Reza Nejabati, Arezoo Rezaie Nezhad Zamani, Samira Nozari, Naser Safaie, Mohammad Nouri, Ahmadreza Jodati

2021Current Molecular Pharmacology14 citationsDOI

Topics & Concepts

Oxidative stressDapagliflozinViability assayMalondialdehydeInflammationLipopolysaccharideTumor necrosis factor alphaPharmacologyCX3CR1NF-κBChemistryProinflammatory cytokineSuperoxide dismutaseTLR4MedicineEndocrinologyInternal medicineCellBiochemistryChemokineType 2 diabetesDiabetes mellitusChemokine receptorChemokine receptors and signalingPancreatitis Pathology and TreatmentNF-κB Signaling Pathways
Dapagliflozin Protects H9c2 Cells Against Injury Induced byLipopolysaccharide via Suppression of CX3CL1/CX3CR1 Axis and NF-κBActivity | Litcius